Skip to Content
Merck
  • Identification of a comprehensive alternative splicing function during epithelial-mesenchymal transition.

Identification of a comprehensive alternative splicing function during epithelial-mesenchymal transition.

iScience (2023-05-01)
Yushan Qiu, Yahong Zhang, Liwen Tian, Quan Zou, Pu Zhao
ABSTRACT

Epithelial-to-mesenchymal transition (EMT) is the underlying mechanism for tumor metastasis and shows the metastatic potential of tumor cells. Although the transcriptional regulation of EMT has been well studied, the role of alternative splicing (AS) regulation in EMT remains largely uncharacterized. The rapid accumulation of RNA-seq datasets has provided the opportunities for developing computational methods to associate mRNA isoform variations with EMT. In this study, we propose regularization models to identify significant AS events during EMT. Our experimental results confirm that the predicted AS events are closely related to apoptosis, focal adhesion-invadopodium shift and tight junction formation that are essential during EMT. Therefore, our study highlights the broad role of posttranscriptional regulation during EMT and identifies key subsets of AS events serving as distinct regulatory nodes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glycine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Anti-Paxillin Antibody, clone 5H11, clone 5H11, Upstate®, from mouse
Sigma-Aldrich
Anti-phospho-Focal Adhesion Kinase (Tyr397) Antibody, clone 18, clone 18, from mouse
Sigma-Aldrich
Anti-β-Actin antibody, Mouse monoclonal, clone AC-15, purified from hybridoma cell culture